HCV protease inhibitor BMS-790052, Purity ≥98%

Cat. No.: X24-06-ZQ890

HCV protease inhibitor BMS-790052, Purity ≥98%

Synonym: 1214735-16-6; HCV protease inhibitor; Daclatasvir

  • MDL: MFCD17129086
  • CAS Number: 1214735-16-6
  • Compound CID: 25154714
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMS-790052, soluble in DMSO and ethanol and insoluble in water, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
738.9
Molecular Formula
C40H50N8O6
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 129 mg/mL (174.59 mM); Water: Insoluble; Ethanol: 129 mg/mL (174.59 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-790052 is utilized in hepatitis C research to inhibit the NS3/4A protease, which is crucial for viral replication.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0